- Home
- AVIR vs KTF Comparison
AVIR vs KTF Comparison
Compare AVIR & KTF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVIR
- KTF
- Stock Information
- Founded
- AVIR 2012
- KTF 1988
- Country
- AVIR United States
- KTF United States
- Employees
- AVIR N/A
- KTF N/A
- Industry
- AVIR Medicinal Chemicals and Botanical Products
- KTF Finance Companies
- Sector
- AVIR Health Care
- KTF Finance
- Exchange
- AVIR Nasdaq
- KTF Nasdaq
- Market Cap
- AVIR 290.4M
- KTF 337.7M
- IPO Year
- AVIR 2020
- KTF N/A
- Fundamental
- Price
- AVIR $3.25
- KTF $9.15
- Analyst Decision
- AVIR Hold
- KTF
- Analyst Count
- AVIR 1
- KTF 0
- Target Price
- AVIR $6.00
- KTF N/A
- AVG Volume (30 Days)
- AVIR 353.8K
- KTF 103.3K
- Earning Date
- AVIR 11-12-2025
- KTF 01-01-0001
- Dividend Yield
- AVIR N/A
- KTF 3.54%
- EPS Growth
- AVIR N/A
- KTF N/A
- EPS
- AVIR N/A
- KTF 0.39
- Revenue
- AVIR N/A
- KTF N/A
- Revenue This Year
- AVIR N/A
- KTF N/A
- Revenue Next Year
- AVIR N/A
- KTF N/A
- P/E Ratio
- AVIR N/A
- KTF $23.10
- Revenue Growth
- AVIR N/A
- KTF N/A
- 52 Week Low
- AVIR $2.46
- KTF $7.40
- 52 Week High
- AVIR $4.02
- KTF $9.12
- Technical
- Relative Strength Index (RSI)
- AVIR 55.27
- KTF 46.95
- Support Level
- AVIR $3.18
- KTF $9.13
- Resistance Level
- AVIR $3.27
- KTF $9.26
- Average True Range (ATR)
- AVIR 0.09
- KTF 0.05
- MACD
- AVIR 0.00
- KTF -0.01
- Stochastic Oscillator
- AVIR 60.00
- KTF 11.94
About AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).
About KTF DWS Municipal Income Trust
DWS Municipal Income Trust is a closed-ended fixed income mutual fund launched and managed by Deutsche Investment Management Americas, Inc. The company invests in the fixed income markets of the United States. The fund invests in investment-grade tax-exempt municipal securities which are exempt from federal income tax. The fund benchmarks the performance of its portfolio against the Barclays Municipal Bond Index. The Fund invests in various states, such as Texas, Florida, Pennsylvania, Illinois, and California.